Journal article
Annie Jeffery, J. Buckman, Emma Francis, Kate Walters, Ian C. K. Wong, Ian C K. Wong cd, David Osborn, Joseph F. Hayes
medRxiv, 2022
medRxiv, 2022
Semantic Scholar
DOI
Cite
Cite
APA
Click to copy
Jeffery, A., Buckman, J., Francis, E., Walters, K., Wong, I. C. K., cd, I. C. K. W., … Hayes, J. F. (2022). A Systematic Review of Long-term Antidepressant Outcomes in Comorbid Depression and Type 2 Diabetes. MedRxiv.
Chicago/Turabian
Click to copy
Jeffery, Annie, J. Buckman, Emma Francis, Kate Walters, Ian C. K. Wong, Ian C K. Wong cd, David Osborn, and Joseph F. Hayes. “A Systematic Review of Long-Term Antidepressant Outcomes in Comorbid Depression and Type 2 Diabetes.” medRxiv (2022).
MLA
Click to copy
Jeffery, Annie, et al. “A Systematic Review of Long-Term Antidepressant Outcomes in Comorbid Depression and Type 2 Diabetes.” MedRxiv, 2022.
BibTeX Click to copy
@article{annie2022a,
title = {A Systematic Review of Long-term Antidepressant Outcomes in Comorbid Depression and Type 2 Diabetes},
year = {2022},
journal = {medRxiv},
author = {Jeffery, Annie and Buckman, J. and Francis, Emma and Walters, Kate and Wong, Ian C. K. and cd, Ian C K. Wong and Osborn, David and Hayes, Joseph F.}
}
Abstract
Background: Depression is a common and chronic comorbidity affecting approximately one in four people with type 2 diabetes (T2DM), and often lasting several years. Past systematic reviews have been unable to identify evidence for longterm (12+ months) antidepressant treatment outcomes in comorbid depression and type 2 diabetes. These reviews are >10years old, included only randomised controlled trials or had limited search strategies. We aimed to systematically review observational studies for long-term outcomes of antidepressant treatment in adults with comorbid depression and T2DM, including broader, up-to-date searches. Methods and findings: This review was pre-registered on PROSPERO (CRD42020182788). We searched seven databases using terms related to depression, T2DM and antidepressant medication. From 14,389 reports retrieved, 63 were screened at full text stage and 0 met inclusion criteria. The reasons for exclusion at full text stage were: Studies did not meet inclusion criteria for antidepressant treatment (n = 50); studies did not meet inclusion criteria for T2DM (n = 36); studies did not meet inclusion criteria for depression (n = 29); studies did not include follow-up time (n = 25); studies did not meet inclusion criteria for observational study (n = 14); studies did not include any measurable outcomes (n = 5); studies did not include a suitable comparison (n = 3). Conclusions: We found no evidence concerning long-term outcomes of antidepressant treatment in individuals with comorbid depression and T2DM. Insufficient ascertainment of antidepressant prescription, case identification, and short follow-up times are the primary reasons for this. Research is urgently required to determine long-term outcomes associated with antidepressant treatment in this patient group
